MADHUSMRUTI KHANDAI

Dr. MADHUSMRUTI KHANDAI

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2022 in C
Verified
Journal Article
Open access
PDF file
JSJagtar Singh
Jagtar Singh
PNPallavi Nayak
Pallavi Nayak
GSGurdeep Singh
Gurdeep Singh
MKMADHUSMRUTI KHANDAI
MADHUSMRUTI KHANDAI
RSRashmi Ranjan Sarangi
Rashmi Ranjan Sarangi
MKMihir Kumar Kar
Mihir Kumar Kar
Recent developments in nanotechnology and process chemistry have expanded the scope of nanostructures to the biomedical field. The ability of nanostructures to precisely deliver drugs to the target site not only reduces the amount of drug needed but also reduces systemic adverse effects. Carbon nanostructures gained traction in pharmaceutical technology in the last decade due to their high stability, ease of synthesis, tunable surface chemistry, and biocompatibility. Fullerene, nanotubes, nanodiamonds, nanodots, and nanoribbons are among the major carbon nanostructures that have been extensively studied for applications in tissue engineering, biosensing, bioimaging, theranostics, drug delivery, and gene therapy. Due to the fluorescent properties of functionalized nanostructures, they have been extensively studied for use as probes in cellular imaging. Moreover, these nanostructures are promising candidates for delivering drugs to the brain, bones, and deep-seated tumors. Still, research gaps need to be addressed regarding the toxicity of these materials in animals as well as humans. This review highlights the physicochemical properties of carbon nanostructures and their categories, methods of synthesis, various techniques for surface functionalization, major biomedical applications, mechanisms involving the cellular uptake of nanostructures, pharmacokinetic considerations, recent patents involving carbon-based nanostructures in the biomedical field, major challenges, and future perspectives.

1 July 2013 in Drug Delivery Letters
Verified
Journal Article
Closed access
PDF file
SCSantanu Chakraborty
Santanu Chakraborty
MKMADHUSMRUTI KHANDAI
MADHUSMRUTI KHANDAI
AGAshoke Kumar Ghosh
Ashoke Kumar Ghosh
Multiple-unit type oral modified drug delivery system of aceclofenac was developed by ionotropic gelation method for targeted drug delivery and to reduce the chances of side effects. Various batches of microspheres were developed by ionotropic gelation method using single and blends of polymers. Along with usual physical properties, the microspheres were also subjected to enteric nature, in-vitro drug release and mucoadhesion studies to investigate a possible sustained drug release and their use in in-vivo as a gastro-protective system for aceclofenac. It was observed that prepared microspheres could be able to restrict the drug release in stomach region and prolong the drug release by adhering on to the intestinal mucosa. In vitro drug release suggested a combination of drug diffusion and spheres erosion could be the release mechanism and it was also found that blend of polymers is more effective in sustaining the drug release than either polymer. Optimized microsphere formulation suggested 71.03 ± 4.94 % edema inhibition at 12 hours and shelf life of about 2.32 years at room temperature. Algino-gelatin multiunit dosage system exhibits promising properties for once daily targeted release form of aceclofenac in order to reduce the side effects and enhance the patient’s compliance.

4 November 2015 in Current Drug Delivery
Verified
Journal Article
Closed access
MKMADHUSMRUTI KHANDAI
MADHUSMRUTI KHANDAI
SCSantanu Chakraborty
Santanu Chakraborty
AGAshoke Ghosh
Ashoke Ghosh
The aim of the present research work is to develop carbo-protein polymeric complex based sustain release microspheres of losartan potassium and investigate the ability of this dosage form to improve the flowability, compressibility and tableting properties of losartan potassium. The influence of silk sericin, alginate and its blend on various physicochemical parameters and in vitro drug release pattern were studied to optimize the concentration of polymeric blend required for 12 h. sustain release. Optimized batch was subjected to different flowability, compressibility and tableting properties studies to observe the effects of carbo-protein microspheres on flow properties. Results indicated that the concentration of sericin was found to be the main influential factor for prolonged drug release. Different micromeritic studies revealed that the poor flowability and compressibility properties of pure losartan potassium were significantly improved by this algino-sericin microspheric dosage form. Research findings also revealed that plasticity, die filling behavior and tableting properties of the pure drug were significantly improved by this microsphere formulation. So these prospective results concluded that carboprotein polymeric microspheres helps to sustain the drug release for prolong hours as well as improve the flowability, compressibility and tableting properties of losartan potassium.

25 August 2026
Verified
Book
Open access
PDF file
MKMADHUSMRUTI KHANDAI
MADHUSMRUTI KHANDAI
IPIswori Prasad Padhy
Iswori Prasad Padhy
BTBichitrananda Tripathy
Bichitrananda Tripathy
PAPrakruti Amin
Prakruti Amin
DSDillip Kumar Sahoo
Dillip Kumar Sahoo
RSRashmi Ranjan Sarangi
Rashmi Ranjan Sarangi
Pharmacy has always been a discipline of the hands as much as the mind. A student learns what a poorly compressed tablet is by feeling one crumble, learns what an aseptic breach looks like by watching a gowned arm pass over an open vial, and learns what patient counselling costs in patience by fumbling through a first explanation of an inhaler. None of that knowledge arrives from a printed page alone. It arrives from being somewhere, doing something, and being corrected. The difficulty is that the places where this learning happens are scarce, expensive and, quite properly, guarded. A sterile filling suite cannot be opened to a class of sixty. A commercial tablet press cannot be stalled for an afternoon so that novices may take turns misaligning the turret. A patient in genuine distress is not a rehearsal partner. The result is a gap that every pharmacy educator recognises: graduates who can recite the principles of a unit operation with precision and yet have never stood beside the machine that performs it. Immersive technology offers one credible way of narrowing that gap. Augmented and virtual reality do not replace the plant, the dispensary or the patient. What they do is manufacture rehearsal — repeatable, inspectable, low-consequence rehearsal — at a cost per learner that falls each year while the cost of the real facility rises. A headset can put a student inside a Grade A zone at nine in the morning and inside a warehouse temperature excursion at eleven, and can do it again tomorrow when the student gets it wrong. This book was written for the elective course Futuristic Pharma Through Augmented Reality and Virtual Reality (AR/VR): Pharma 4.0. It follows the five units of that syllabus, but it opens with an orientation chapter, because the immersive tools make very little sense in isolation. They are the visible surface of a much larger shift in how pharmaceutical manufacture is instrumented, modelled and inspected. A headset connected to nothing is a novelty. A headset connected to a validated data layer is an instrument. Three commitments shaped the writing. The first is that vendor enthusiasm is not evidence, and the text says plainly where a claimed benefit rests on a handful of small studies rather than on settled practice. The second is that a pharmacy graduate is not being trained as a software engineer; the technical passages go far enough to make a student a competent specifier and a sceptical buyer, and no further. The third is that regulation is not an obstacle bolted on at the end. In a regulated industry, an immersive artefact that cannot be validated, versioned and defended in an audit is an artefact that will never leave the demonstration room. Compliance is therefore discussed inside each chapter rather than quarantined in one. Every chapter carries an original figure, closes with a summary and a set of review questions, and assumes only the pharmaceutics, pharmacology and quality assurance a sixth-semester student already holds. Chapter 6 is deliberately practical: it walks the mini project from a one-line scope statement to a defended demonstration, because the syllabus asks for a built artefact and building one is where most of the learning actually occurs. A closing caution. This field moves quickly, and the specific products named in these pages will change. The names are included because a student needs concrete handholds, not because any of them is a permanent fixture. What should outlast them is the habit of asking, of any immersive proposal placed on a desk: what problem does this solve, for whom, at what cost, with what evidence, and how would we prove to an inspector that it works?

18 June 2015 in Drug Delivery Letters
Verified
Journal Article
Closed access
PDF file
SCSantanu Chakraborty
Santanu Chakraborty
NKNitesh Kumar
Nitesh Kumar
MKMADHUSMRUTI KHANDAI
MADHUSMRUTI KHANDAI
AGAshoke K. Ghosh
Ashoke K. Ghosh
The objective behind this study is to prepare a transdermal therapeutic system for aceclofenac and ameliorate to evaluate the influence of chemical permeation enhancer (oleic acid) on drug permeation through the human cadaver skin. The influence of permeation enhancer on permeation flux (J), enhancement ratio of flux (ERflux) and permeability coefficient (Pss) was compared with the control batch (without permeation enhancer) by using one-way ANOVA followed by multiple comparison analysis. The drug permeation from the formulations was best characterized by Higuchi diffusion followed by case II to super case II transport mechanism. The optimized patch containing 5% w/w concentration of permeation enhancer was able to increase more than fivefold of drug permeation. Skin irritation studies suggest that optimized transdermal patch is non-irritating and safe for dermal application. Scanning electron microscopy, differential scanning calorimetry and X-ray diffraction studies confirmed the amorphous state of aceclofenac in the transdermal patch. So it is concluded from the above research that the prepared transdermal therapeutic system was dermatologically safe and able to deliver effective amount of aceclofenac through the transdermal route.

13 July 2026
Verified
Book
Open access
PDF file
MKMADHUSMRUTI KHANDAI
MADHUSMRUTI KHANDAI
RKRaja Rajeswari Kamisetti
Raja Rajeswari Kamisetti
SSSarangadhara Sahu
Sarangadhara Sahu
RBRadhesh Kumar Badatya
Radhesh Kumar Badatya
NPNarayan Pradhan
Narayan Pradhan
KPKalki Ranjan Priyadarsan
Kalki Ranjan Priyadarsan
Regulatory affairs is one of those most dynamic and important fields of the pharmaceutical sciences. In addition to the science of drug development (chemistry, pharmacology, toxicology and clinical medicine), a regulatory professional needs to understand the law, policy, and strategy leading to the availability of medicines for patients.With the increasing demand for a complete, easy-to-understand, and current source of information on pharmaceutical regulatory affairs for students of Pharmacy in India, this textbook has been developed to cover all aspects from basics to advanced topics of the field with a particular emphasis on the Indian regulatory requirements and a global perspective.The contents of the book are arranged in fifteen chapters with a logical development in order from historical and theoretical context to more specific subjects. To assist exam preparation, each chapter is followed by multiple-choice and short answer questions.The authors invite feedback from students and teachers as to how this resource can be continually improved.